PrE0204: A multi-institutional, single arm, two-stage phase II trial o
- This topic has 0 replies, 1 voice, and was last updated 7 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
PrE0204: A multi-institutional, single arm, two-stage phase II trial of nab-paclitaxel and gemcitabine for first-line treatment of patients with advanced or metastatic cholangiocarcinoma—A PrECOG LLC study.
http://abstracts.asco.org/199/AbstView_199_193174.html
Please note that information regarding clinical trials is being provided for informational purposes only. The Cholangiocarcinoma Foundation does not endorse any specific clinical trial. Please discuss any questions you may have about clinical trials with your healthcare provider.
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.